Aorta and skeletal muscle NO synthase expression in experimental heart failure

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 11, 1996, Pages 2241-2248

  Comini, Laura ^a   Bachetti, Tiziana ^a   Gaia, Giuseppina ^a   Pasini, Evasio ^a   Agnoletti, Laura ^a   Pepi, Patrizia ^b   Ceconi, Claudio ^b   Curello, Salvatore ^b   Ferrari, Roberto ^b  

^a IRCCS   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Congestive heart failure; NO synthase

Indexed keywords

ARGININE; ENDOTHELIUM DERIVED RELAXING FACTOR; FREE RADICAL; MONOCROTALINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DESCENDING AORTA; EXTENSOR DIGITORUM LONGUS MUSCLE; FEMALE; HEART FAILURE; IMMUNOBLOTTING; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; SKELETAL MUSCLE; SMOOTH MUSCLE; SOLEUS MUSCLE; VASCULAR ENDOTHELIUM;

ANIMALIA;

EID: 0030297359     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0216     Document Type: Article

References (38)

1. BACHETTI T, COMINI L, PEDERSINI P, AGNOLETTI L, GAIA G, BELLET M, BENIGNO M, CURELLO S, FERRARI R, 1995. While tumor necrosis factor alpha does not, norepinephrine affects the nitric oxide pathways in endothelial cells (Abstract). J Mol Cell Cardiol 27: A377.
2. BALLIGAND JL, UNGUREANU D, KELLY RA, KOBZIK L, PIMENTAL D, MICHEL T, SMITH TW, 1993. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 91: 2314-2319.
3. BERNOCCHI P, CECONI C, PEDERSINI P, PASINI E, CURELLO S, FERRARI R, 1996. Skeletal muscle metabolism in experimental heart failure. J Mol Cell Cardiol 28: 000-000.
4. BRADFORD MM, 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
5. BUSSE R, MULSCH A, 1990. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 275: 87-90.
6. CECONI C, CONDORELLI E, QUINZANINI M, RODELLA A, FERRARI R, HARRIS P, 1989. Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats in congestive heart failure. Cardiovasc Res 23: 674-682.
7. CHARPIE JR, WEBB RC, 1993. Vascular myocyte-derived nitric oxide is an autocrine that limits vasoconstriction. Biochem Biophys Res Commun 194: 763-768.
8. COMINI L, AGNOLETTI G, PANZALI A, MANTERO G, PASINI E, GAIA G, ALBERTINI A, FERRARI R, 1995. Activation of ANP synthesis during congestive heart failure in rats treated with monocrotaline. Am J Physiol 268: H391-H398.
9. COMINI L, GAIA G, CURELLO S, CECONI C, PASINI E, BENIGNO M, BACHETTI T, FERRARI R, 1996. Overt heart failure chronically stimulates heat shock protein 72 in the heart but not in peripheral skeletal muscle. Cardiovasc Res 31: 882-890.
10. DREXLER H, RIEDE U, MUNZEL T, KONIG H, FUNKE E, JUST H, 1992. Alterations of skeletal muscle in chronic heart failure. Circulation 85: 1751-1759.
11. DUSTING GJ, 1995. Nitric oxide in cardiovascular disorders. J Vasc Res 32: 143-161.
12. FERRARI R, BACHETTI T, CONFORTINI R, OPASICH C, FEBO O, CORTI A, CASSANI G, VISIOLI O, 1995. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 92: 1479-1486.
13. FULTON RM, HUTCHINSON EC, JONES AM, 1952. Ventricular weight in cardiac hypertrophy. Br Heart J 14: 413-420.
14. FURCHGOTT RF, ZAWADSKI JV, 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376.
15. GELLER DA, LOWENSTEIN CJ, SHAPIRO RA, NUSSLER AK, DISILVIO M, WANG SC, NAKAYAMA DK, SIMMONS RL, SNYDER SH, BILLIAR TR, 1993. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 90: 3491-3495.
16. GRIENDLING KK, MINIERI CA, OLLERENSHAW JD, ALEXANDER RW, 1994. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth cells. Circ Res 74: 1141-1148.
17. HATTORI R, SASE K, EIZAWA H, KOSUGA K, AOYAMA T, INOUE R, SASAYAMA S, KAWAI C, YUI Y, 1994. Structure and function of nitric oxide synthases. Intl J Cardiol 47: S71-S75.
18. KATZ SD, BIASUCCI L, SABBA C, STROM JA, JONDEAU G, GALVAO M, SOLOMON S, NIKOLIC SD, FORMAN R, LEJEMTEL TH, 1992. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 19: 918-925.
19. KATZ SD, SCHWARTZ M, YUEN J, LEJEMTEL TH, 1993. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation 88: 55-61.
20. KATZ SD, RAO R, BERMAN JW, SCHWARTZ M, DEMOPOULOS L, BIJOU R, LEJEMTEL TH, 1994. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Circulation 90: 12-16.
21. KAY JM, HARRIS P, HEATH D, 1967. Pulmonary hypertension in rats produced by the ingestion of Crotalaria spectabilis seeds. Thorax 22: 176-179.
22. KOBZIK L, REID MB, BREDT DS, STAMLER JS, 1994. Nitric oxide in skeletal muscle. Nature 372: 546-548.
23. KUBO SH, RECTOR TS, BANK AJ, WILLIAMS RE, HEIFETZ SM, 1991. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 84: 1589-1596.
24. LAEMMLI UK, 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277: 680-685.
25. LAMAS S, MARSDEN PA, LI GK, TEMPST P, MICHEL T, 1992. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 88: 6348-6352.
26. LUSCHER TF, NOLL G, 1993. Endothelium-dependent vasomotion in aging, hypertension and heart failure. Circulation 87 [Suppl. 7]: 97-103.
27. MARSDEN PA, HENG HHQ, SCHERER SW, STEWART RJ, HALL AV, SHI XM, TSUI LC, SCHAPPERT KT, 1993. Structure and Chromosomal localization of the human constitutive nitric oxide synthase gene. J Biol Chem 268: 17478-17488.
28. MONCADA S, PALMER RMJ, HIGGS EA, 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142.
29. MONCADA S, PALMER RMJ, 1992. Endothelium-dependent relaxation and the discovery of the L-arginine: NO pathway. In: Endothelial Regulation of Vascular Tone, Ryan US, Rubanyi GM, eds, Marcel Dekker Inc: New York, 21-36.
30. NARGI FE, YANG TJ, 1993. Optimization of the L-M cell bioassay for quantitating tumor necrosis factor α in serum and plasma. J Immunol Methods 159: 81-91.
31. NORIS M, MORIGI M, DONADELLI R, AIELLO S, FOPPOLO M, TODESCHINI M, ORISIO S, REMUZZI G, REMUZZI A, 1995. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 76: 536-543.
32. PALMER RMJ, ASHTON DS, MONCADA S, 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666.
33. SCHINI VR, VANHOUTTE PM, 1991. L-arginine evokes both endothelium-dependent and -independent relaxations in L-arginine depleted aorta of the rat. Circ Res 68: 209-216.
34. STAMLER JS, SINGEL DS, LOSCALZO J, 1992. Biochemistry of nitric oxide and its redox-activated forms. Science 258: 1898-1902.
35. TOWBIN H, STAEHELIN T, GORDON J, 1979. ELectrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354.
36. WOOD KS, BUGA GM, BYRNS RE, IGNARRO U, 1990. Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxide. Biochem Biophys Res Commun 170: 80-88.
37. XIE Q, CHO HI, CALAYCAY J, MUMFORD RA, SWIDEREK KM, LEE TD, DING A, TROSO T, NATHAN C, 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228.
38. YOKOYAMA T, VACA L, ROSSEN RD, DURANTE W, HAZARIKA P, MANN DL, 1993. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 92: 2303-2312.